Multiple recurrent stent thrombosis in a patient with coexisting clopidogrel resistance and increased anticardiolipin antibodies: A case report

Case Reports in Medicine

Volumn 2010, Issue , 2010, Pages

  Middlebrooks, Erik H ^a   Panda, Mukta ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85025432656     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2010/974149     Document Type: Article

References (19)

1. R. L. Bick, "Antiphospholipid thrombosis syndromes," Hematology/Oncology Clinics of North America, vol. 17, no. 1, pp. 115-147, 2003.
2. K. E. Morton, T. P. Gavaghan, and S. A. Krilis, "Coronary artery bypass graft failure - an autoimmune phenomenon?" Lancet, vol. 2, no. 8520, pp. 1353-1357,1986.
3. D. F.Muir, A. Stevens, R. O. Napier-Hemy, F. Fath-Ordoubadi, and N. Curzen, "Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma," International Journal of Cardiovascular Interventions, vol. 5, no. 1, pp. 44-46, 2003. (Pubitemid 36227315)
4. H.-M. Su, K.-T. Lee, C.-S. Chu, S.-H. Sheu, and W.-T. Lai, "Acute thrombosis after elective direct intracoronary stenting in primary antiphospholipid syndrome: a case report," Kaohsiung Journal of Medical Sciences, vol. 19, no. 4, pp. 177-182, 2003. (Pubitemid 36723335)
5. A. Weissman and N. L. Coplan, "Antiphospholipid antibody syndrome and acute stent thrombosis," Reviews in Cardiovascular Medicine, vol. 7, no. 4, pp. 244-246, 2006. (Pubitemid 46139121)
6. P. Buonamici, R. Marcucci, A. Migliorini, G. F. Gensini, A. Santini, R. Paniccia, G. Moschi, A. M. Gori, R. Abbate, and D. Antoniucci, "Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis," Journal of the American College of Cardiology, vol. 49, no. 24, pp. 2312-2317, 2007. (Pubitemid 46891710)
7. W. Hochholzer, D. Trenk, H.-P. Bestehorn, B. Fischer, C. M. Valina, M. Ferenc, M. Gick, A. Caputo, H. J. Büttner, and F.-J. Neumann, "Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement," Journal of the American College of Cardiology, vol. 48, no. 9, pp. 1742-1750, 2006. (Pubitemid 44648629)
8. C. Miret, R. Cervera, J. C. Reverter, M. García-Carrasco, M. Ramos, M. Mollà, J. Font, and M. Ingelmo, "Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?" Clinical and Experimental Rheumatology, vol. 15, no. 5, pp. 541-544, 1997. (Pubitemid 27408011)
9. A. D. Michelson, M. D. Linden, M. I. Furman, Y. Li, M. R. Barnard, M. L. Fox, W. C. Lau, T. J. McLaughlin, and A. L. Frelinger, "Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'," Journal of Thrombosis and Haemostasis, vol. 5, no. 1, pp. 75-81, 2007. (Pubitemid 44921070)
10. P. A. Gurbel, K. P. Bliden, K. M. Hayes, J. A. Yoho, W. R. Herzog, and U. S. Tantry, "The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting," Journal of the American College of Cardiology, vol. 45, no. 9, pp. 1392-1396, 2005.
11. L. Bonello, L. Camoin-Jau, S. Arques, C. Boyer, D. Panagides, O. Wittenberg, M.-C. Simeoni, P. Barragan, F. Dignat-George, and F. Paganelli, "Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance. A multicenter randomized prospective study," Journal of the American College of Cardiology, vol. 51, no. 14, pp. 1404-1411, 2008. (Pubitemid 351447314)
12. H. Neubauer, S. Lask, A. Engelhardt, and A. Mügge, "How to optimise clopidogrel therapy? Reducing the low-response incidence by aggregometry-guided therapy modification," Thrombosis and Haemostasis, vol. 99, no. 2, pp. 357-362, 2008. (Pubitemid 351230967)
13. S. R. Mehta, J.-P. Bassand, S. Chrolavicius, R. Diaz, K. A.A. Fox, C. B. Granger, S. Jolly, H.-J. Rupprecht, P. Widimsky, and S. Yusuf, "Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy," American Heart Journal, vol. 156, no. 6, pp. 1080-1088.e1, 2008.
14. P. A. Gurbel, K. P. Bliden, K. A. Zaman, J. A. Yoho, K. M. Hayes, and U. S. Tantry, "Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading with Eptifibatide to Arrest the Reactivity of Platelets (CLEAR Platelets) Study," Circulation, vol. 111, no. 9, pp. 1153-1159, 2005.
15. P. Soltész, K. Veres, G. Lakos, E. Kiss, L. Muszbek, and G. Szegedi, "Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients," Lupus, vol. 12, no. 4, pp. 302-307, 2003. (Pubitemid 36458661)
16. S. Miyakis, M. D. Lockshin, T. Atsumi, D. W. Branch, R. L. Brey, R. Cervera, R. H. W. M. Derkesen, P. G. De Groot, T. Koike, P. L. Meroni, G. Reber, Y. Shoenfeld, A. Tincani, P. G. Vlachoyiannopoulos, and S. A. Krilis, "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)," Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295-306, 2006.
17. I. Ikonomidis, J. Lekakis, G. Vamvakou, S. Loizou, I. Revela, F. Andreotti, D. TH. Kremastinos, and P. Nihoyannopoulos, "Aspirin reduces anticardiolipin antibodies in patients with coronary artery disease," European Journal of Clinical Investigation, vol. 36, no. 12, pp. 839-843, 2006. (Pubitemid 44707082)
18. W. F. Baker Jr., R. L. Bick, and J. Fareed, "Controversies and unresolved issues in antiphospholipid syndrome pathogenesis and management," Hematology/Oncology Clinics of North America, vol. 22, no. 1, pp. 155-174, 2008.
19. N. Abuaf, O. Meyer, S. Laperche, et al., "Conclusions of the first French workshop of standardization of anticardiolipin antibody determination associated with autoimmune pathology," Annales de Biologie Clinique, vol. 52, no. 5, pp. 365-373, 1994. (Pubitemid 24274119)